Internal Medicine, Nephrology · Chula Vista, CA
NPI
1255394789
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
416 Broadway
Chula Vista, CA, 91910
Phone (619) 427-1144
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
2,528 services
Medicare patients, 2024
430
Average age 74
Drug cost, 2024
$2.0M
5,181 prescriptions
Company payments, 2025
$83.53
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jill M Meyer was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 398 times for 155 patients. In total Jill M Meyer billed 2,528 services in 24 codes, and Medicare paid $211K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 398 | 155 | $12.82 | $5,102 |
| 99214 Office E&M - Established | Office | 384 | 154 | $72.07 | $28K |
| 99232 Hospital E&M - Subsequent | Facility | 359 | 118 | $63.52 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 316 | 105 | $96.05 | $30K |
| 90960 ESRD Related Services (not dialysis) | Office | 223 | 34 | $294.51 | $66K |
| 99458 E&M - Miscellaneous | Office | 170 | 94 | $33.44 | $5,685 |
| 99223 Hospital E&M - Initial | Facility | 116 | 103 | $139.65 | $16K |
| 99457 E&M - Miscellaneous | Office | 103 | 103 | $42.44 | $4,371 |
| 99454 E&M - Miscellaneous | Office | 85 | 85 | $43.97 | $3,737 |
| 90961 ESRD Related Services (not dialysis) | Office | 29 | 15 | $245.55 | $7,121 |
| 99453 E&M - Miscellaneous | Office | 26 | 26 | $18.33 | $477 |
| 99204 Office E&M - New | Office | 18 | 18 | $107.88 | $1,942 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $105.66 | $1,162 |
By year: 2022 $256K for 2,258 services; 2023 $189K for 2,012 services; 2024 $211K for 2,528 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jill M Meyer prescribed most often to Medicare patients was Atorvastatin Calcium, with 310 prescriptions and refills. In total Jill M Meyer wrote 5,181 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 310 | 845 | 103 | $4,304 |
| Furosemide Generic | 303 | 762 | 93 | $2,052 |
| Amlodipine Besylate Generic | 289 | 673 | 88 | $1,887 |
| Farxiga Dapagliflozin Propanediol | 281 | 586 | 77 | $311K |
| Lokelma Sodium Zirconium Cyclosilicate | 249 | 342 | 66 | $204K |
| Losartan Potassium Generic | 248 | 639 | 79 | $2,066 |
| Lisinopril Generic | 230 | 564 | 68 | $1,661 |
| Ozempic Semaglutide | 213 | 312 | 51 | $288K |
| Allopurinol Generic | 203 | 545 | 65 | $1,808 |
| Jardiance Empagliflozin | 181 | 348 | 50 | $195K |
| Spironolactone Generic | 136 | 351 | 51 | $1,269 |
| Bumetanide Generic | 117 | 306 | 39 | $8,628 |
| Tamsulosin Hcl Generic | 107 | 283 | 33 | $2,005 |
| Nifedipine Er Nifedipine | 106 | 211 | 25 | $4,457 |
| Carvedilol Generic | 102 | 237 | 30 | $897 |
Brand drugs: 1,664 claims; generic drugs: 3,480 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jill M Meyer $83.53 ($83.53 in general payments such as food, travel and fees) from 4 companies. The largest payer was NxStage Medical, Inc. with $42.98.
| Company | Payments | Amount |
|---|---|---|
| NxStage Medical, Inc. | 1 | $42.98 |
| Fresenius USA Marketing, Inc. | 2 | $37.78 |
| Travere Therapeutics, Inc. TVTX | 2 | $2.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.